Advancing Breast Cancer Survival Research Through Open Access
Join a global community of oncologists, clinical researchers, epidemiologists, and patient advocates advancing understanding of breast cancer survivorship, treatment outcomes, and quality of life. Membership provides predictable publishing costs, expert editorial support, and worldwide visibility for your crucial research benefiting survivors worldwide.
About the Journal
The Journal of Breast Cancer Survival is a peer-reviewed, open access publication dedicated to publishing original research, clinical studies, systematic reviews, and case reports focused on breast cancer survivorship, treatment outcomes, quality of life, and long-term care. Our scope encompasses survival rates, recurrence patterns, late effects of treatment, psychosocial aspects, rehabilitation, supportive care interventions, and health economics related to breast cancer survivors.
Our distinguished editorial board includes oncologists, breast cancer specialists, epidemiologists, psycho-oncology researchers, and patient advocates from leading cancer centers and research institutions worldwide. We welcome clinical trials, translational research, epidemiological studies, qualitative research on survivor experiences, intervention studies, and health services research that advances understanding of survivorship and improves outcomes for patients and their families.
We maintain rigorous ethical and methodological standards for all submissions. Authors must provide institutional ethics approvals, informed consent documentation, transparent conflict of interest disclosures, and complete data availability statements. We encourage adherence to CONSORT for randomized trials, PRISMA for systematic reviews, STROBE for observational studies, and COREQ for qualitative research. Membership never influences editorial decisions; all manuscripts undergo identical expert peer review by oncology specialists.
Research Scope
Survival outcomes, treatment effects, quality of life, psychosocial support, recurrence prevention, and rehabilitation interventions
Article Types
Clinical trials, systematic reviews, observational studies, qualitative research, case reports, and intervention evaluations
Expert Reviewers
Board-certified oncologists, survivorship researchers, and psycho-oncology specialists with clinical expertise
Why Researchers Choose Membership
Publishing breast cancer survival research should accelerate patient outcomes and support survivor communities, not create financial barriers or publication uncertainty. The oncology field faces unique challenges in scholarly publishing that our membership program directly addresses. Many researchers struggle with unpredictable publication costs that complicate grant budgeting, long review cycles that delay sharing critical findings with treating clinicians, and limited visibility when research remains behind paywalls inaccessible to survivors and patient advocates. Our membership program provides comprehensive solutions to these challenges.
Eliminate Cost Uncertainty
Accelerate Publication
Reach the Community
Rigorous Expert Review
Membership Tiers
Select the tier that matches your publication volume and career stage. Whether you are an individual oncology researcher conducting clinical or translational survivorship research, a graduate student developing expertise in psycho-oncology and quality of life outcomes, an academic cancer center supporting multiple faculty researchers across oncology specialties, or a pharmaceutical company developing novel breast cancer therapeutics and supportive care interventions, our membership tiers provide meaningful cost savings and dedicated author support throughout the entire publication lifecycle.
Individual Researcher
$5,400/yr $2,970 per year- Unlimited submissions
- 30% special issue discount
- Author/co-author eligible
- Editorial guidance
- Membership certificate
- 2-year option: $3,465
Student
$3,200/yr $2,080 per year- Unlimited submissions
- Primary/co-author eligible
- CV certificate
- Compliance guidance
- Requires advisor letter
- 2-year option: $2,405
Institutional
$9,500 per year- 20 manuscripts APC waiver
- Departmental sharing
- Centralized billing
- Platform recognition
- Onboarding support
- 2-year: $11,500 (30)
Corporate
$5,600/yr $3,640 for 10 articles- 10 staff manuscripts/year
- Themed issue contributions
- Recognition certificate
- Same review standards
- Stakeholder recognition
- 2-year: $4,225 (15/yr)
Submit Your Research
Two convenient pathways to share your breast cancer survival research with the global oncology and patient care community.
ManuscriptZone Portal
Full-featured online submission system with real-time tracking, reviewer communication, and comprehensive revision management tools.
Submit via ManuscriptZoneSimple Submission Form
Quick and direct manuscript upload with essential metadata collection for straightforward submissions.
Submit via FormHow to Apply
Ready to join the growing community of breast cancer researchers benefiting from membership? Email info@openaccesspub.org to begin your application. Our dedicated membership team responds within 48 hours with detailed next steps and pricing confirmation for your selected tier.
Contact Us
Send your name, institutional affiliation, and desired tier
Confirm Details
We verify eligibility and confirm final pricing details
Complete Payment
Secure invoice processing with flexible payment options
Start Publishing
Submit your manuscripts with all membership benefits active
Important Terms
Membership benefits apply during active term and do not roll over unless specified in writing.
Early renewal before expiration qualifies for a 20% discount on renewal fees.
APC relief applies after peer review and formal acceptance, not upon submission.
Membership does not guarantee acceptance; all manuscripts undergo standard expert review.
Editorial Independence: Membership reduces publication costs but never influences peer review outcomes or acceptance decisions. Every manuscript submitted to our journal is evaluated on scientific merit and methodological rigor alone. The editorial team and peer reviewers operate independently from membership administration.
Common Questions
No. APC waivers and membership benefits apply only to manuscripts that successfully complete the full peer review process and receive formal acceptance from our oncology editorial team.
Yes. All co-authors listed on your manuscripts receive full APC relief within your membership allowance, making multi-author collaboration cost-effective.
Unlimited submission benefits exclude special issues, but members receive a generous 30% discount on all special issue APCs.
Absolutely. Contact our dedicated membership team anytime to upgrade your tier and receive a revised agreement reflecting your new benefits.
Advance Breast Cancer Survival Research Today
Remove publication barriers. Reach clinicians, researchers, survivors, and advocates worldwide. Accelerate breakthroughs in survivorship outcomes.